Androgen receptor antagonism by divalent ethisterone conjugates in castrate-resistant prostate cancer cells

ACS Chemical Biology

Volumn 7, Issue 10, 2012, Pages 1693-1701

  Levine, Paul M ^a   Lee, Eugine ^a   Greenfield, Alex ^a   Bonneau, Richard ^a   Logan, Susan K ^a,b   Garabedian, Michael J ^b   Kirshenbaum, Kent ^a  

^a NEW YORK UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ETHISTERONE; LIGAND; PEPTIDE; ANDROGEN RECEPTOR ANTAGONIST;

ARTICLE; CANCER CELL; CANCER RESISTANCE; CASTRATION; CELL CYCLE ARREST; CHROMATIN IMMUNOPRECIPITATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA BINDING; DNA SYNTHESIS INHIBITION; DRUG ANTAGONISM; EMBRYO; FLOW CYTOMETRY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; ANALOGS AND DERIVATIVES; CASTRATION RESISTANT PROSTATE CANCER; CELL CYCLE; CELL PROLIFERATION; DRUG EFFECTS; HEK293 CELL LINE; METABOLISM; SYNTHESIS; TUMOR CELL LINE;

ANDROGEN RECEPTOR ANTAGONISTS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; ETHISTERONE; GENE EXPRESSION; HEK293 CELLS; HUMANS; MALE; MICROARRAY ANALYSIS; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT;

EID: 84867786721     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb300332w     Document Type: Article

References (61)

1. Meimetis, L. G., Williams, D. E., Mawji, N. R., Banuelos, C. A., Lal, A. A., Park, J. J., Tien, A. H., Fernandez, J. G., de Voogd, N. J., Sadar, M. D., and Andersen, R. J. (2011) Niphatenones, Glycerol Ethers from the Sponge Niphates Digitalis Block Androgen Receptor Transcriptional Activity in Prostate Cancer Cells: Structure Elucidation, Synthesis, and Biological Activity J. Med. Chem. 55, 503-514
2. Hodgson, M. C., Astapova, I., Hollenberg, A. N., and Balk, S. P. (2007) Activity of Androgen Receptor Antagonist Bicalutamide in Prostate Cancer Cells is Independent of NCoR and SMRT Corepressors Cancer Res. 67, 8388-8395
3. Lassi, K. and Dawson, N. A. (2009) Emerging Therapies in Castrate-Resistant Prostate Cancer Curr. Opin. Oncol. 21, 260-265
4. Rennie, P. S. and Nelson, C. C. (1998) Epigenetic Mechanisms for Progression of Prostate Cancer Cancer Metastasis Rev. 17, 401-409
5. Clegg, N. J., Wongvipat, J., Tran, C., Ouk, S., Dilhas, A., Joseph, J., Chen, Y., Grillot, K., Bischoff, E. D., Cai, L., Aparicio, A., Dorow, S., Arora, V., Shao, G., Qian, J., Zhao, H., Yang, G., Cao, C., Sensintaffar, J., Wasielewska, T., Herbert, M. R., Bonnefous, C., Darimont, B., Scher, H. I., Smith-Jones, P. M., Klang, M., Smith, N. D., de Stanchina, E., Wu, N., Ouerfelli, O., Rix, P., Heyman, R., Jung, M. E., Sawyers, C. L., and Hager, J. H. (2012) ARN-509: A Novel Anti-Androgen for Prostate Cancer Treatment Cancer Res. 15, 1494-1503
6. Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., and Montori, V. M. (2010) Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab. 95, 2536-2559
7. Gelmann, E. P. (2002) Molecular Biology of the Androgen Receptor J. Clin. Oncol. 20, 3001-3015
8. Edwards, J., Krishna, N. S., Grigor, K. M., and Bartlett, J. M. S. (2003) Androgen Receptor Gene Amplification and Protein Expression in Hormone Refractory Prostate Cancer Br. J. Cancer 89, 552-556
9. Georget, V., Terouanne, B. A., Nicolas, J.-C., and Sultan, C. (2002) Mechanism of Antiandrogen Action: Key Role of Hsp90 in Conformational Change and Transcriptional Activity of the Androgen Receptor Biochemistry 41, 11824-11831
10. Heinlein, C. A. and Chang, C. (2004) Androgen Receptor in Prostate Cancer Endocr. Rev. 25, 276-308
11. Schaufele, F., Carbonell, X., Guerbadot, M., Borngraeber, S., Chapman, M. S., Ma, A. A. K., Miner, J. N., and Diamond, M. I. (2005) The Structural Basis of Androgen Receptor Activation: Intramolecular and Intermolecular Amino-Carboxy Interactions Proc. Natl. Acad. Sci. U.S.A. 102, 9802-9807
12. Gioeli, D., Ficarro, S. B., Kwiek, J. J., Aaronson, D., Hancock, M., Catling, A. D., White, F. M., Christian, R. E., Settlage, R. E., Shabanowitz, J., Hunt, D. F., and Weber, M. J. (2002) Androgen Receptor Phosphorylation. Regulation and Identification of the Phosphorylation Sites J. Biol. Chem. 277, 29304-29314
13. Shaffer, P. L., Jivan, A., Dollins, D. E., Claessens, F., and Gewirth, D. T. (2004) Structural Basis of Androgen Receptor Binding to Selective Androgen Response Elements Proc. Natl. Acad. Sci. U.S.A. 101, 4758-4763
14. He, B., Minges, J. T., Lee, L. W., and Wilson, E. M. (2002) The FXXLF Motif Mediates Androgen Receptor-Specific Interactions with Coregulators J. Biol. Chem. 277, 10226-10235
15. McGinley, P. L. and Koh, J. T. (2007) Circumventing Anti-Androgen Resistance by Molecular Design J. Am. Chem. Soc. 129, 3822-3823
16. Tran, C., Ouk, S., Clegg, N. J., Chen, Y., Watson, P. A., Arora, V., Wongvipat, J., Smith-Jones, P. M., Yoo, D., Kwon, A., Wasielewska, T., Welsbie, D., Chen, C. D., Higano, C. S., Beer, T. M., Hung, D. T., Scher, H. I., Jung, M. E., and Sawyers, C. L. (2009) Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer Science 324, 787-790
17. Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., and Sawyers, C. L. (2004) Molecular Determinants of Resistance to Antiandrogen Therapy Nat. Med. 10, 33-39
18. Andersen, R. J., Mawji, N. R., Wang, J., Wang, G., Haile, S., Myung, J.-K., Watt, K., Tam, T., Yang, Y. C., Banuelos, C. A., Williams, D. E., McEwan, I. J., Wang, Y., and Sadar, M. D. (2010) Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor Cancer Cell 17, 535-546
19. Dubrovska, A., Kim, C., Elliott, J., Shen, W., Kuo, T.-H., Koo, D.-I., Li, C., Tuntland, T., Chang, J., Groessl, T., Wu, X., Gorney, V., Ramirez-Montagut, T., Spiegel, D. A., Cho, C. Y., and Schultz, P. G. (2011) A Chemically Induced Vaccine Strategy for Prostate Cancer ACS Chem. Biol. 6, 1223-1231
20. Estébanez-PerpinÌá, E., Arnold, L. A., Nguyen, P., Rodrigues, E. D., Mar, E., Bateman, R., Pallai, P., Shokat, K. M., Baxter, J. D., Guy, R. K., Webb, P., and Fletterick, R. J. (2007) A Surface on the Androgen Receptor that Allosterically Regulates Coactivator Binding Proc. Natl. Acad. Sci. U.S.A. 104, 16074-16079
21. BuzoÌn, V., CarboÌ, L. R., Estruch, S. B., Fletterick, R. J., and Estébanez-PerpinÌá, E. (2012) A Conserved Surface on the Ligand Binding Domain of Nuclear Receptors for Allosteric Control Mol. Cell. Endocrinol. 348, 394-402
22. Levine, P. M., Imberg, K., Garabedian, M. J., and Kirshenbaum, K. (2012) Multivalent Peptidomimetic Conjugates: A Versatile Platform for Modulating Androgen Receptor Activity J. Am. Chem. Soc. 134, 6912-6915
23. Kiessling, L. L., Gestwicki, J. E., and Strong, L. E. (2000) Synthetic Multivalent Ligands in the Exploration of Cell-Surface Interactions Curr. Opin. Chem. Biol. 4, 696-703
24. Childs-Disney, J. L., Tsitovich, P. B., and Disney, M. D. (2011) Using Modularly Assembled Ligands to Bind RNA Internal Loops Separated by Different Distances ChemBioChem 12, 2143-2146
25. Englund, E. A., Wang, D., Fujigaki, H., Sakai, H., Micklitsch, C. M., Ghirlando, R., Martin-Manso, G., Pendrak, M. L., Roberts, D. D., Durell, S. R., and Appella, D. H. (2012) Programmable Multivalent Display of Receptor Ligands Using Peptide Nucleic Acid Nanoscaffolds Nat. Commun. 3, 614
26. Bryson, D. I., Zhang, W., McLendon, P. M., Reineke, T. M., and Santos, W. L. (2011) Toward Targeting RNA Structure: Branched Peptides as Cell-Permeable Ligands to TAR RNA ACS Chem. Biol. 7, 210-217
27. Fournel, S., Wieckowski, S., Sun, W., Trouche, N., Dumortier, H., Bianco, A., Chaloin, O., Habib, M., Peter, J.-C., Schneider, P., Vray, B., Toes, R. E., Offringa, R., Melief, C. J. M., Hoebeke, J., and Guichard, G. (2005) C3-Symmetric Peptide Scaffolds are Functional Mimetics of Trimeric CD40L Nat. Chem. Biol. 1, 377-382
28. Kitov, P. I., Sadowska, J. M., Mulvey, G., Armstrong, G. D., Ling, H., Pannu, N. S., Read, R. J., and Bundle, D. R. (2000) Shiga-Like Toxins are Neutralized by Tailored Multivalent Carbohydrate Ligands Nature 403, 669-672
29. Lee, J., Udugamasooriya, D. G., Lim, H.-S., and Kodadek, T. (2010) Potent and Selective Photo-Inactivation of Proteins with Peptoid-Ruthenium Conjugates Nat. Chem. Biol. 6, 258-260
30. Raskatov, J. A., Hargrove, A. E., So, A. Y., and Dervan, P. B. (2012) Pharmacokinetics of Py-Im Polyamides Depend on Architecture: Cyclic versus Linear J. Am. Chem. Soc. 134, 7995-7999
31. Holub, J. M., Garabedian, M. J., and Kirshenbaum, K. (2011) Modulation of Human Estrogen α Receptor Activity by Multivalent Estradiol- Peptidomimetic Conjugates Mol. BioSyst. 7, 337-345
32. Yuasa, H., Honma, H., Hashimoto, H., Tsunooka, M., and Kojima-Aikawa, K. (2007) Pentamer is the Minimum Structure for Oligomannosylpeptoids to Bind to Concanavalin A Bioorg. Med. Chem. Lett. 17, 5274-5278
33. Lee, M. M., Pushechnikov, A., and Disney, M. D. (2009) Rational and Modular Design of Potent Ligands Targeting the RNA That Causes Myotonic Dystrophy 2 ACS Chem. Biol. 4, 345-355
34. Miller, S. M., Simon, R. J., Ng, S., Zuckermann, R. N., Kerr, J. M., and Moos, W. H. (1995) Comparison of the Proteolytic Susceptibilities of Homologous L-Amino Acid, D-Amino Acid, and N -substituted Glycine Peptide and Peptoid Oligomers Drug Dev. Res. 35, 20-32
35. Tan, N. C., Yu, P., Kwon, Y.-U., and Kodadek, T. (2008) High-Throughput Evaluation of Relative Cell Permeability Between Peptoids and Peptides Bioorg. Med. Chem. 16, 5853-5861
36. Maayan, G., Ward, M. D., and Kirshenbaum, K. (2009) Folded Biomimetic Oligomers for Enantioselective Catalysis Proc. Natl. Acad. Sci. U.S.A. 106, 13679-13684
37. Maayan, G., Ward, M. D., and Kirshenbaum, K. (2009) Metallopeptoids Chem. Commun. 56-58
38. Huang, M. L., Shin, S. B. Y., Benson, M. A., Torres, V. J., and Kirshenbaum, K. (2012) A Comparison of Linear and Cyclic Peptoid Oligomers as Potent Antimicrobial Agents ChemMedChem 7, 114-122
39. Fowler, S. A. and Blackwell, H. E. (2009) Structure-Function Relationships in Peptoids: Recent Advances Toward Deciphering the Structural Requirements for Biological Function Org. Biomol. Chem. 7, 1508-1524
40. Chongsiriwatana, N. P., Patch, J. A., Czyzewski, A. M., Dohm, M. T., Ivankin, A., Gidalevitz, D., Zuckermann, R. N., and Barron, A. E. (2008) Peptoids that Mimic the Structure, Function, and Mechanism of Helical Antimicrobial Peptides Proc. Natl. Acad. Sci. U.S.A. 105, 2794-2799
41. Murphy, J. E., Uno, T., Hamer, J. D., Cohen, F. E., Dwarki, V., and Zuckermann, R. N. (1998) A Combinatorial Approach to the Discovery of Efficient Cationic Peptoid Reagents for Gene Delivery Proc. Natl. Acad. Sci. U.S.A. 95, 1517-1522
42. Udugamasooriya, D. G., Dineen, S. P., Brekken, R. A., and Kodadek, T. (2008) A Peptoid Antibody Surrogate that Antagonizes VEGF Receptor 2 Activity J. Am. Chem. Soc. 130, 5744-5752
43. Zuckermann, R. N., Kerr, J. M., Kent, S. B. H., and Moos, W. H. (1992) Efficient Method for the Preparation of Peptoids [oligo(N -substituted glycines)] by Submonomer Solid-Phase Synthesis J. Am. Chem. Soc. 114, 10646-10647
44. Lee, Y. and Sampson, N. S. (2006) Romping the Cellular Landscape: Linear Scaffolds for Molecular Recognition Curr. Opin. Struct. Biol. 16, 544-550
45. Yoo, B., Shin, S. B. Y., Huang, M. L., and Kirshenbaum, K. (2010) Peptoid Macrocycles: Making the Rounds with Peptidomimetic Oligomers Chem.î - ̧Eur. J. 16, 5528-5537
46. Holub, J. M., Garabedian, M. J., and Kirshenbaum, K. (2007) Peptoids on Steroids: Precise Multivalent Estradiol-Peptidomimetic Conjugates Generated via Azide-Alkyne [3 + 2] Cycloaddition Reactions QSAR Comb. Sci. 26, 1175-1180
47. Shin, S. B. Y., Yoo, B., Todaro, L. J., and Kirshenbaum, K. (2007) Cyclic Peptoids J. Am. Chem. Soc. 129, 3218-3225
48. Holub, J. M. and Kirshenbaum, K. (2010) Tricks with Clicks: Modification of Peptidomimetic Oligomers via Copper-Catalyzed Azide-Alkyne [3 + 2] Cycloaddition Chem. Soc. Rev. 39, 1325-1337
49. Rezai, T., Bock, J. E., Zhou, M. V., Kalyanaraman, C., Lokey, R. S., and Jacobson, M. P. (2006) Conformational Flexibility, Internal Hydrogen Bonding, and Passive Membrane Permeability: Successful in Silico Prediction of the Relative Permeabilities of Cyclic Peptides J. Am. Chem. Soc. 128, 14073-14080
50. Rezai, T., Yu, B., Millhauser, G. L., Jacobson, M. P., and Lokey, R. S. (2006) Testing the Conformational Hypothesis of Passive Membrane Permeability Using Synthetic Cyclic Peptide Diastereomers J. Am. Chem. Soc. 128, 2510-2511
51. Culig, Z., Hoffmann, J., Erdel, M., Eder, I. E., Hobisch, A., Hittmair, A., Bartsch, G., Utermann, G., Schneider, M. R., Parczyk, K., and Klocker, H. (1999) Switch from Antagonist to Agonist of the Androgen Receptor Blocker Bicalutamide is Associated with Prostate Tumour Progression in a New Model System Br. J. Cancer 81, 242-251
52. Waller, A., Sharrard, R., Berthon, P., and Maitland, N. (2000) Androgen Receptor Localisation and Turnover in Human Prostate Epithelium Treated with the Antiandrogen, Casodex J. Mol. Endocrinol. 24, 339-351
53. Jones, J. O., An, W. F., and Diamond, M. I. (2009) AR Inhibitors Identified by High-Throughput Microscopy Detection of Conformational Change and Subcellular Localization ACS Chem. Biol. 4, 199-208
54. Ozers, M. S., Marks, B. D., Gowda, K., Kupcho, K. R., Ervin, K. M., De Rosier, T., Qadir, N., Eliason, H. C., Riddle, S. M., and Shekhani, M. S. (2006) The Androgen Receptor T877A Mutant Recruits LxxLL and FxxLF Peptides Differently than Wild-Type Androgen Receptor in a Time-Resolved Fluorescence Resonance Energy Transfer Assay Biochemistry 46, 683-695
55. Osguthorpe, D. J. and Hagler, A. T. (2011) Mechanism of Androgen Receptor Antagonism by Bicalutamide in the Treatment of Prostate Cancer Biochemistry 50, 4105-4113
56. Nickols, N. G. and Dervan, P. B. (2007) Suppression of Androgen Receptor-Mediated Gene Expression by a Sequence-Specific DNA-Binding Polyamide Proc. Natl. Acad. Sci. U.S.A. 104, 10418-10423
57. Wang, Q., Li, W., Zhang, Y., Yuan, X., Xu, K., Yu, J., Chen, Z., Beroukhim, R., Wang, H., Lupien, M., Wu, T., Regan, M. M., Meyer, C. A., Carroll, J. S., Manrai, A. K., Janne, O. A., Balk, S. P., Mehra, R., Han, B., Chinnaiyan, A. M., Rubin, M. A., True, L., Fiorentino, M., Fiore, C., Loda, M., Kantoff, P. W., Liu, X. S., and Brown, M. (2009) Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer Cell 138, 245-256
58. Zhang, J., Gao, N., DeGraff, D. J., Yu, X., Sun, Q., Case, T. C., Kasper, S., and Matusik, R. J. (2010) Characterization of Cis Elements of the Probasin Promoter Necessary for Prostate-Specific Gene Expression Prostate 70, 934-951
59. Barber, R. D., Harmer, D. W., Coleman, R. A., and Clark, B. J. (2005) GAPDH as a Housekeeping Gene: Analysis of GAPDH mRNA Expression in a Panel of 72 Human Tissues Physiol. Genomics 21, 389-395
60. Gautier, L., Cope, L., Bolstad, B. M., and Irizarry, R. A. (2004) Affy-Analysis of Affymetrix GeneChip Data at the Probe Level Bioinformatics 20, 307-315
61. Gentleman, R., Carey, V., Bates, D., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., Hornik, K., Hothorn, T., Huber, W., Iacus, S., Irizarry, R., Leisch, F., Li, C., Maechler, M., Rossini, A., Sawitzki, G., Smith, C., Smyth, G., Tierney, L., Yang, J., and Zhang, J. (2004) Bioconductor: Open Software Development for Computational Biology and Bioinformatics Genome Biol. 5, R80